[HTML][HTML] A label-free proteomic approach for the identification of biomarkers in the exosome of endometrial cancer serum

E Sommella, V Capaci, M Aloisio, E Salviati… - Cancers, 2022 - mdpi.com
Simple Summary Endometrial cancers (ECs) are mostly adenocarcinomas arising from the
inner part of the uterus. The identification of serum biomarkers may be useful for an early …

[HTML][HTML] Phospho-DIGE Identified Phosphoproteins Involved in Pathways Related to Tumour Growth in Endometrial Cancer

V Capaci, G Arrigoni, L Monasta, M Aloisio… - International Journal of …, 2023 - mdpi.com
Endometrial cancer (EC) is the most common gynecologic malignancy of the endometrium.
This study focuses on EC and normal endometrium phosphoproteome to identify …

[HTML][HTML] A Multi-omics approach revealed common dysregulated pathways in type one and type two endometrial cancers

V Capaci, L Monasta, M Aloisio, E Sommella… - International Journal of …, 2023 - mdpi.com
Endometrial cancer (EC) is the most frequent gynecologic cancer in postmenopausal
women. Pathogenetic mechanisms that are related to the onset and progression of the …

[HTML][HTML] Two dimensional-difference in gel electrophoresis (2D-DIGE) proteomic approach for the identification of biomarkers in endometrial cancer serum

B Ura, S Biffi, L Monasta, G Arrigoni, I Battisti… - Cancers, 2021 - mdpi.com
Simple Summary Endometrial cancer is the most common gynecologic malignancy arising
from the endometrium. Identification of serum biomarkers could be beneficial for its early …

[HTML][HTML] Gel-based proteomic identification of suprabasin as a potential new candidate biomarker in endometrial cancer

F Celsi, L Monasta, G Arrigoni, I Battisti… - International Journal of …, 2022 - mdpi.com
Endometrial cancer (EC) is the most frequent gynaecologic cancer in postmenopausal
women. We used 2D-DIGE and mass spectrometry to identify candidate biomarkers in …

[HTML][HTML] A proteomic approach for the identification of biomarkers in endometrial cancer uterine aspirate

B Ura, L Monasta, G Arrigoni, C Franchin, O Radillo… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Endometrial cancer arises from the endometrium. It has a slow progression and a reported
survival rate of 75%. The identification of soluble biomarkers in the uterine aspirate may be …

The Deep Proteomics Approach Identified Extracellular Vesicular Proteins Correlated to Extracellular Matrix in Type One and Two Endometrial Cancer

V Capaci, F Kharrat, A Conti, E Salviati… - International Journal of …, 2024 - mdpi.com
Among gynecological cancers, endometrial cancer is the most common in developed
countries. Extracellular vesicles (EVs) are cell-derived membrane-surrounded vesicles that …

[HTML][HTML] Phosphoproteins Involved in the Inhibition of Apoptosis and in Cell Survival in the Leiomyoma

B Ura, L Monasta, G Arrigoni, I Battisti… - Journal of Clinical …, 2019 - mdpi.com
Uterine leiomyomas are benign smooth muscle cell tumors originating from the myometrium.
In this study we focus on leiomyoma and normal myometrium phosphoproteome, to identify …

[HTML][HTML] Identification of proteins with different abundance associated with cell migration and proliferation in leiomyoma interstitial fluid by proteomics

B Ura, F Scrimin, C Franchin, G Arrigoni… - Oncology …, 2017 - spandidos-publications.com
Uterine leiomyoma is the most common female reproductive tract benign tumor. Little is
known about protein composition and changes in the leiomyoma interstitial fluid (IF). The …

[HTML][HTML] Dysregulated chaperones associated with cell proliferation and negative apoptosis regulation in the uterine leiomyoma

B Ura, F Scrimin, G Arrigoni, M Aloisio… - Oncology …, 2018 - spandidos-publications.com
Uterine leiomyomas are benign smooth muscle cell tumors that originate from the
myometrium. In this study we focus on dysregulated chaperones associated with cell …